Cargando…

Autologous hematopoietic stem cell transplant for autoimmune diseases: evolution,evidence of efficacy, and real-world economics

Despite an increase in the development of biological therapies for autoimmune disease (AID), a proportion of patients remain treatment refractory, resulting in long term morbidity and increased rates of mortality. Furthermore, maintenance biologic therapies are associated with treatment-related side...

Descripción completa

Detalles Bibliográficos
Autores principales: Massey, Jennifer C., Moore, John J., Milliken, Samuel T., Ma, David D. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia-Pacific Blood and Marrow Transplantation Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599833/
https://www.ncbi.nlm.nih.gov/pubmed/37885825
http://dx.doi.org/10.31547/bct-2018-009

Ejemplares similares